ICTUS Study: International Citicoline Trial on Acute Stroke "ICTUS"

Terminated

Phase 3 Results N/A

Summary of Purpose

Citicoline is a safe drug approved in some countries for the treatment of acute ischemic stroke. The drug has shown some evidence of efficacy in a pooled analysis, based on four clinical trials done in USA with oral citicoline.The purpose of the study is confirm the results obtained in the pooled analysis, that is,... Trial Stopped: With 2078 patients, a statistical stopping boundary has now been crossed

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 June 2012.

1 Oct 2006 30 May 2006 1 Feb 2012 1 Mar 2012 1 Jun 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts